PET Imaging Radiotracers of Chemokine Receptors

Molecules

Yusuke Higashi¹  Santosh R. Alluri²  Kun-Eek Kil² 

[1] Department of Medicine, Tulane University, New Orleans, LA 70112, USA;University of Missouri Research Reactor, University of Missouri, Columbia, MO 65211, USA;

关键词: chemokine receptor;    chemokine;    positron emission tomography (PET);    in vivo imaging;   

DOI  :  10.3390/molecules26175174

来源: DOAJ

【 摘 要 】

Chemokines and chemokine receptors have been recognized as critical signal components that maintain the physiological functions of various cells, particularly the immune cells. The signals of chemokines/chemokine receptors guide various leukocytes to respond to inflammatory reactions and infectious agents. Many chemokine receptors play supportive roles in the differentiation, proliferation, angiogenesis, and metastasis of diverse tumor cells. In addition, the signaling functions of a few chemokine receptors are associated with cardiac, pulmonary, and brain disorders. Over the years, numerous promising molecules ranging from small molecules to short peptides and antibodies have been developed to study the role of chemokine receptors in healthy states and diseased states. These drug-like candidates are in turn exploited as radiolabeled probes for the imaging of chemokine receptors using noninvasive in vivo imaging, such as positron emission tomography (PET). Recent advances in the development of radiotracers for various chemokine receptors, particularly of CXCR4, CCR2, and CCR5, shed new light on chemokine-related cancer and cardiovascular research and the subsequent drug development. Here, we present the recent progress in PET radiotracer development for imaging of various chemokine receptors.

【 授权许可】

Unknown